Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Recurrent wheezing is associated with intestinal protozoan infections in Warao Amerindian children in Venezuela: a cross-sectional survey

  • Marcella MA Overeem1Email author,
  • Lilly M Verhagen1, 2,
  • Peter WM Hermans1,
  • Berenice del Nogal3, 4,
  • Adriana Márquez Sánchez4,
  • Natacha Martinez Acevedo4,
  • Rosalicia Ramirez Murga2,
  • Jeroen Roelfsema5,
  • Elena Pinelli5 and
  • Jacobus H de Waard2
Contributed equally
BMC Infectious Diseases201414:293

DOI: 10.1186/1471-2334-14-293

Received: 6 September 2013

Accepted: 14 May 2014

Published: 29 May 2014

Abstract

Background

While in developed countries the prevalence of allergic diseases is rising, inflammatory diseases are relatively uncommon in rural developing areas. High prevalence rates of helminth and protozoan infections are commonly found in children living in rural settings and several studies suggest an inverse association between helminth infections and allergies. No studies investigating the relationship between parasitic infections and atopic diseases in rural children of developing countries under the age of 2 years have been published so far. We performed a cross-sectional survey to investigate the association of helminth and protozoan infections and malnutrition with recurrent wheezing and atopic eczema in Warao Amerindian children in Venezuela.

Methods

From August to November 2012, 229 children aged 0 to 2 years residing in the Orinoco Delta in Venezuela were enrolled. Data were collected through standardized questionnaires and physical examination, including inspection of the skin and anthropometric measurements. A stool sample was requested from all participants and detection of different parasites was performed using microscopy and real time polymerase chain reaction (PCR).

Results

We observed high prevalence rates of atopic eczema and recurrent wheezing, respectively 19% and 23%. The prevalence of helminth infections was 26% and the prevalence of protozoan infections was 59%. Atopic eczema and recurrent wheezing were more frequently observed in stunted compared with non-stunted children in multivariable analysis (OR 4.3, 95% CI 1.3 – 13.6, p = 0.015 and OR 4.5, 95% CI 0.97 – 21.2, p = 0.055). Furthermore, recurrent wheezing was significantly more often observed in children with protozoan infections than in children without protozoan infections (OR 6.7, 95% CI 1.5 – 30.5).

Conclusions

High prevalence rates of atopic eczema and recurrent wheezing in Warao Amerindian children under 2 years of age were related to stunting and intestinal protozoan infections respectively. Helminth infections were not significantly associated with either atopic eczema or recurrent wheezing.

Keywords

Atopic eczema Helminth Indigenous children Malnutrition Protozoa Recurrent wheezing

Background

The incidence of allergic diseases is rising in industrialized countries and urbanized areas worldwide [1, 2]. While genetic factors are important in determining the risk of development of asthma, environmental factors are still likely to be the primary determinants of expression of atopic diseases [3]. Atopic disorders comprise a range of allergic diseases including allergic asthma, anaphylaxis, allergic rhinitis and atopic eczema. Atopic eczema affects approximately 5-20% of children worldwide and mostly children living in urban areas [4, 5]. The highest prevalence rates of atopic eczema (more than 15%) are observed in urban Africa, the Baltics, Australia, New Zealand and Northern and Western Europe. The lowest prevalence rates (less than 5%) are observed in China, Eastern Europe, and Central Asia [4]. In several studies a lower prevalence rate of allergic diseases in rural compared to urban children has been observed [58]. This difference has been attributed to differences in exposure to aeroallergens and irritant environmental triggers as well as infection with pathogens that can act as allergic disease risk modifiers [9, 10].

The so called ‘hygiene hypothesis’ proposes that diminished microbial exposure during early childhood increases susceptibility to allergic diseases [11]. The implementation of hygiene measures as well as the use of antibiotics and vaccines can explain the decreased exposure to different pathogens, particularly in Western countries. Originally, it was proposed that an increased exposure to bacteria and viruses would lead to a strong Th1 response limiting the development of a Th2 immune response, which is typically associated with allergic diseases. However, helminth infections are known to induce a Th2 response and an inverse association between infection with different helminth species and allergic conditions has been reported [12]. It has recently become clear that the interaction between helminth infection and allergic diseases involves regulatory T cells, that dampen both Th1 and Th2 effector responses [13, 14].

Although several studies have demonstrated a negative association between intestinal helminth infections and allergic diseases, this association is not consistently observed [2]. In a study including Ethiopian children, there was no significant association between helminth infections and atopic diseases [9], while in pediatric studies from Brazil both positive as well as negative associations between Ascaris lumbricoides infection and atopic diseases were observed [1517]. A systematic review and meta-analysis of epidemiologic studies on the association between intestinal parasite infection and the presence of atopy showed a consistent protective effect of infection with Ascaris lumbricoides, Trichuris trichiura, hookworm and Schistosoma sp. [18].

There are only a few reports assessing the association of protozoan infections with allergic diseases [17, 1921]. Giardia lamblia was associated with allergic diseases in children from an urban area of Venezuela [19] while no significant relationship between detection of G. lamblia and allergies was observed in urban areas of Brazil [21]. Both studies included children older than 2 years of age. To our knowledge, the relationship between protozoan infections and allergic symptoms has not been investigated in children under 2 years of age.

In rural areas of Venezuela, parasitic infections are commonly observed in children under 16 years of age [22]. Children aged between 12 and 24 months are at a critical stage of growth and development which increases their vulnerability to the detrimental effects of helminth infections. Recent evidence suggests that if interventions to reduce helminth infections and associated malnutrition are not implemented before 24 months of age, future growth and development will be affected [23, 24]. Helminthiasis and giardiasis in school-age Venezuelan children were associated with acute and chronic nutritional status respectively [25]. The vicious cycle of malnutrion and parasitic infections is associated with immune modulation. A disturbed immune balance may play a role in the development of immune-mediated diseases like atopy.

We performed a cross-sectional survey to study the association of helminth infections, protozoan infections and malnutrition with atopic eczema and recurrent wheezing in Warao Amerindian children aged 0 to 2 years.

Methods

Study population

The Delta Amacuro or Orinoco Delta comprises 4 municipalities. This cross-sectional survey was undertaken in 11 geographically spread Warao villages, located in the largest of the 4 municipalities, Antonio Diaz, which has almost 19,000 inhabitants. Warao Amerindian children aged between 0 and 2 years were included. With a population of 155,000, the Warao people are the second most important Native American group in Venezuela. They live in about 300 geographically isolated villages that are spread throughout this area, where they receive little medical attention and live under precarious sanitary conditions, experiencing a high incidence of infectious diseases.

Data collection

This study was carried out from August 1, 2012 to November 7, 2012. First, all children attending health clinics in the 11 villages were recruited. Subsequently, door-to-door visits were conducted in each of the 11 communities. The investigators stayed in every community for approximately three to seven days. If an individual was not home during the door-to-door visits, return visits were made to include all age-eligible children living in the communities at the time of survey. After written informed consent and the collection of demographic information, face-to-face interviews using a standardized questionnaire were conducted with parents or guardians of the children. The history included questions concerning age, sex and habitation of the child. A physical examination including anthropometric measurements of the child and inspection of the skin was performed and documented on a standardized data collection sheet. Children were measured for height and weight without shoes and in light indoor clothing using a tape measure with a precision to 0.1 cm. Weight was measured using an electronic digital scale, with a maximum capacity of 150 kg and a precision to 0.1 kg. A stool sample was requested from all participants. Stool samples were preserved in sodium acetate-acetic-formalin (SAF) preservative [26] and stored at 4°C until microscopical examination by experienced laboratory technicians for the presence of helminths and intestinal protozoa. An aliquot of the unpreserved sample was mixed with ethanol 96%. Fecal samples in ethanol were stored at -70°C until DNA isolation with the High Pure PCR Template Preparation Kit (Roche, Almere, The Netherlands). Real-Time PCR of fecal samples was performed on the Roche LightCycler 480 system using the Roche FastStart Kit. Detection of the protozoa Dientamoeba fragilis, Giardia lamblia and Cryptosporidium sp. was done in one multiplex PCR with Phocine Herpes Virus (PhHV) as an internal control using primers and probes described by Verweij et al. [27, 28] PCR on the nematodes Ascaris lumbricoides, Strongyloides stercoralis, Ancylostoma duodenale and Necator americanus was also performed in a multiplex PCR with primers and probes described by Basuni et al. [29]. The primers and probes sequences are listed in Table 1, including the amount that was used in a single reaction. All PCRs were carried out in 25 μl reactions in the presence of 4 μg BSA fraction V (Sigma-Aldrich, Zwijndrecht, The Netherlands). After an initial activation step of 10 minutes at 95°C the reaction consisted of 45 cycles at 95°C for 10 seconds, 58°C for 20 seconds and 72°C for 20 seconds.
Table 1

Multiplex PCR on protozoa and nematodes

Name

Sequence (label & quencher)

Amount

Target organism

Multiplex PCR on protozoa

  

Crypto-tp

Tex Red-ccaatcacagaatcatcagaatcgactggtatc-BHQ2

5 pmol

Cryptosporidium sp.

Crypto CrF

cgcttctctagccttttcatga

15 pmol

 

Crypto CrR

cttcacgtgtgtttgccaat

15 pmol

 

Giardia-tp

Fam-cccgcggcggtccctgctag-BHQ1

1 pmol

G. lamblia

Giardia 80 F

gacggctcaggacaacggtt

5 pmol

 

Giardia 127R

ttgccagcggtgtccg

5 pmol

 

Df-172

Vic-caattctagccgcttat-BHQ1

5 pmol

D. fragilis

Df 124-F

caacggatgtcttggctcttta

14 pmol

 

Df 221-R

tgcattcaaagatcgaacttatcac

14 pmol

 

PhHV TP

Cy5-tttttatgtgtccgccaccatctggatc-BHQ2

7.5 pmol

Phocine Herpes virus

PhHV-F

gggcgaatcacagattgaatc

10 pmol

 

PhHV-R

gcggttccaaacgtaccaa

10 pmol

 

Multiplex PCR on nematodes

  

Ad155MGB-TP

Fam-atcgtttaccgactttag-BHQ1MGB

2.5 pmol

A. duodenale

Ad125F

gaatgacagcaaactcgttgttg

5 pmol

 

Ad195R

atactagccactgccgaaacgt

5 pmol

 

Na-TP

Tex Red-gtgttcagcaattcccgtttaagtgaag-BHQ2

1.25 pmol

N. americanus

Na58F

ctgtttgtcgaacggtacttgc

5 pmol

 

Na158R

ataacagcgtgcacatgttgc

5 pmol

 

Alum124T-TP

Vic-ttggcggacaattgcatgcgat-BHQ1

1.25 pmol

Ascaris sp.

Alum96F

gtaatagcagtcggcggtttctt

2 pmol

 

Alum183R

gcccaacatgccacctattc

2 pmol

 

Stro TP

ATTO425-acacaccggccgtcgctgc-BHQ1

1.25 pmol

S. stercoralis

Stro18s-1530F

gaattccaagtaaacgtaagtcattagc

2.5 pmol

 

Stro18s-1630R

tgcctctggatattgctcagttc

2.5 pmol

 

Definitions of atopic eczema, recurrent wheezing and malnutrition

Eczema was investigated by a questionnaire and physical examination using standardized instruments based on the United Kingdom Working Party (UKWP) criteria/Nottingham protocol [30]. Cases of flexural dermatitis were more specifically assessed for severity using the SCORAD protocol [31]. Eczema was defined by at least one presentation during the first 2 years of life of an itchy skin condition plus 3 or more of the following: 1) history of involvement of flexural sites including the cheeks; 2) history of atopic disease in a first degree relative; 3) history of generally dry skin in last year and 4) visible flexural dermatitis or dermatitis affecting the cheeks or forehead and outer limbs (Table 2) [30]. These strict criteria were used since in these communities other causes of “itchy skin” are common (e.g. scabies, insect bites or helminth induced rashes); for the same reason the diagnosis of atopic eczema always included positive findings upon medical examination of the child. Wheezing was defined as recurrent wheezing when the child suffered from two or more wheezing episodes in the past 12 months. Recurrent wheezing was only assessed in children aged 12 months and above (n=123). The anthropometric measurements were transformed into weight-for-age (WAZ), height-for-age (HAZ), and weight-for-height (WHZ) Z scores based on WHO standard reference populations using WHO Anthro software [32, 33]. Malnutrition was defined as underweight (WAZ < -2 SD), stunting (HAZ < -2 SD), and wasting (WHZ < -2 SD) [32].
Table 2

Questionnaire used for defining atopic eczema

Question:

Yes, n%

No, n%

1a. In the last year, has your child had an itchy skin condition – by itchy we mean scratching or rubbing the skin?

90 (39)

139 (61)

1b. Has your child has an itchy skin condition in the last week?

58 (65)

30 (35)

2. Has the skin condition ever affected the skin creases in the past - by skin creases we mean one of the following condition you see below:

65 (72)

25 (28)

 Fronts of elbows

36 (40)

54 (60)

 Behind the knees

29 (32)

61 (68)

 Fronts of ankles

32 (36)

58 (64)

 Around the neck

41 (46)

49 (54)

 Around the eyes

19 (21)

71 (79)

 On the cheeks

21 (23)

69 (77)

 On both forearms

31 (35)

59 (65)

 On both legs

33 (37)

57 (63)

3. Does anyone in your child’s immediate family (mother, father, brother or sister) suffer from eczema, hay fever or asthma?

84 (37)

144 (63)

4. In the last year has your child suffered from a dry skin in general?

42 (18)

186 (82)

Physical examination:

Flexural dermatitis

Dermatitis cheeks/forehead and outer limbs

5. Is there visible flexural dermatitis or dermatitis affecting cheeks/forehead and outer limbs?

66 (29)

81 (35)

Eczema was defined by at least one presentation during the first 2 years of life of an itchy skin condition (question 1a) plus 3 or more of the following: 1) history of involvement of flexural sites including the cheeks (question 2); 2) history of atopic disease in a first degree relative (question 3); 3) history of generally dry skin in last year (question 4) and 4) visible flexural dermatitis or dermatitis affecting the cheeks or forehead and outer limbs. (question 5).

Statistical analysis

Categorical variables were analyzed using univariate analysis. To determine which characteristics were associated with atopic eczema and recurrent wheezing, multivariable logistic regression models were built. The variables of interest (i.e. atopic eczema, recurrent wheezing, malnutrition, protozoan infections and helminth infections) were included in the multivariable model irrespective of their p-values in the univariate analysis. Age and gender were included in the multivariable model if p <0.20 in univariate analyses. Statistical analyses were performed using the SPSS program for Windows version 20.0 (SPSS Inc, Chicago, IL).

Ethical considerations

The nature and objectives of the study were explained to the parents of children in Spanish and/or in their native language. This study was a pilot study within a larger study on response to pneumococcal vaccination which was approved by the ethical committee of the Instituto de Biomedicina, Caracas 1010A, issued on the 22th of March 2011 in Caracas, Venezuela. Furthermore, the study was approved by the Servicio de Atención y Orientación Indígena (S.A.O.I) on the 2th of December 2010 in Tucupita, Venezuela. Children were enrolled if their parents or primary caregivers provided written informed consent. If parents or guardians did not speak Spanish, the questions were translated into the native Warao language by local translators. The aims of the research and the definitions and explanations of the terms used were discussed with community elders, community health workers and local translators prior to the inclusion of patients. Preliminary testing of the questionnaires was then carried out by the local translators together with the survey staff. After these test interviews, the questionnaire was slightly modified to adapt it to the local terminology. If parents or primary caregivers were illiterate, consent forms were read to them in Spanish and/or in their native language and they were signed by means of a thumb print. Anti-helminthic and anti-protozoal treatment based on the feces microscopy results was provided free of charge by the study team.

Results

From August to November 2012, 229 children 0 to 24 months of age were included. All parents/guardians were willing to answer questions and cooperate with physical examination of the child. Fecal samples were collected from 100 children (44%). Children from whom stool samples were obtained were more likely to suffer from stunting than children from whom stool samples were not obtained (56% vs. 40%, p = 0.013). Characteristics of the study population are shown in Table 3.
Table 3

Characteristics of the study population (n = 229)

Age (months), mean (SD),

13 (6)

Male

115 (50)

Female

114 (50)

Community, n%

 

Araguabisi

16 (7)

Araguaimujo

27 (12)

Arature

21 (9)

Bonoina

24 (11)

Guayaboroina

9 (4)

Guayo

26 (11)

Ibaruma

20 (9)

Jobure de Curiapo

31 (14)

Merejina

14 (6)

Nabasanuka

26 (11)

Winikina

15 (7)

Malnourished: stunting (HAZ < -2 SD), n%

107 (47)

Malnourished: underweight (WAZ < -2 SD), n%

41 (18)

Malnourished: wasting (WHZ < -2 SD), n%

15 (7)

Atopic eczema, n%

43 (19)

Recurrent wheezing in children ≥ 12 months of age, n%

28 (23)

Helminth infection, n%

26 (26)

Ascaris lumbricoides

15 (15)

Trichuris trichiura

4 (4)

Strongyloides stercoralis

11 (11)

Necator americanus

2 (2)

Ancylostoma duodenale

1 (1)

Protozoan infection, n%

59 (59)

Giardia lamblia

47 (47)

Dientamoebe fragilis

4 (4)

Cryptosporidium parvum

15 (15)

Blastocystis hominis

5 (5)

Iodamoeba sp

1 (1)

Entamoeba dispar

1 (1)

Chilomastix mesnili

1 (1)

The prevalence of atopic eczema in the study population was 19% (n = 43) and recurrent wheezing was observed in 23% (n = 28). A borderline significant trend towards more atopic eczema in children suffering from recurrent wheezing was observed (32% vs. 16%, p = 0.055). Infection with an intestinal parasite was present in 70% (n = 70) of the children that handed in fecal samples. In 26 children (26%), a helminth infection was detected while 59 children (59%) suffered from a protozoan infection. G. lamblia was the most frequently detected pathogen, infecting 47 of the included children (47%). Characteristics of included children and the association between parasitic infections and atopic eczema and recurrent wheezing are presented in Tables 4 and 5. There were no significant differences regarding age or sex between the children with or without atopic eczema. The prevalence of atopic eczema was significantly higher in stunted compared with non-stunted children in multivariable analysis (OR 4.3, 95% CI 1.3 – 13.6, p = 0.015).
Table 4

Characteristics of Warao Amerindian children 0 to 2 years of age, malnutrition and parasitic infections compared with atopic eczema*

Characteristics

Eczema

No eczema

Univariate analysis

 

Multivariable analysis

 

(n=23)

(n=77)

p-value

OR (95% CI)

OR (95% CI)

Age (months), mean (SD)

14 (6)

13 (6)

0.38

1.0 (0.96-1.1)

#

Sex, n (%)

  

0.62

  

 Male

13 (57)

39 (51)

 

1

#

 Female

10 (43)

38 (49)

 

0.79 (0.31-2.0)

 

Stunting vs. non-stunting (HAZ < -2 SD), n (%)

18 (78)

38 (49)

0.018

3.7 (1.2-11.0)

4.3 (1.3-13.6)

Underweight vs. not underweight (WAZ < -2 SD), n (%)

5 (22)

17 (22)

0.97

0.98 (0.32-3.0)

0.52 (0.15-1.8)

Wasting vs. non-wasting (WHZ < -2 SD), n (%)

0 (0)

6 (8)

#

#

#

Parasitic infections, n (%)

     

 Helminth infection present vs. absent

6 (26)

20 (26)

0.99

1.0 (0.35-2.9)

0.98 (0.32-3.0)

 Protozoan infection present vs. absent

11 (48)

48 (62)

0.22

0.55 (0.22-1.4)

0.69 (0.26-1.8)

*These analyses were performed on children from who we collected stool samples (n=100).

Table 5

Characteristics of Warao Amerindian children 0 to 2 years of age, malnutrition and parasitic infections compared with recurrent wheezing*

Characteristics

Recurrent wheezing

No recurrent wheezing

Univariate analysis

 

Multivariable analysis

 

(n=16)

(n=45)

p-value

OR (95% CI)

OR (95% CI)

Age (months), mean (SD)

18 (3)

17 (4)

0.57

1.0 (0.90-1.2)

#

Sex, n (%)

  

0.10

  

 Male

13 (81)

26 (58)

 

1

1

 Female

3 (19)

19 (42)

 

0.32 (0.079-1.3)

0.28 (0.061-1.3)

Stunting vs. non-stunting (HAZ < -2 SD), n (%)

12 (75)

25 (56)

0.18

2.4 (0.67-8.6)

4.5 (0.97-21.2)

Underweight vs. not underweight (WAZ < -2 SD), n (%)

4 (25)

12 (27)

0.90

0.92 (0.25-3.4)

0.78 (0.15-4.1)

Wasting vs. non-wasting (WHZ < -2 SD), n (%)

0 (0)

4 (9)

#

#

#

Parasitic infections, n (%)

     

 Helminth infection present vs. absent

10 (63)

27 (60)

0.86

0.90 (0.28-2.9)

0.77 (0.20-3.0)

 Protozoan infection present vs. absent

13 (81)

21 (47)

0.024

5.0 (1.2-19.8)

6.7 (1.5-30.5)

*These analyses were performed on children from who we collected stool samples (n=61).

The prevalence of recurrent wheezing in the last 12 months was 21% (n=48) and for children aged 12 months and above, it was 23% (n=28). There were no significant differences regarding age or sex between the children with or without recurrent wheezing. Stunting was more often observed in children with recurrent wheezing compared with children without recurrent wheezing, but this difference was not statistically significant in multivariable analysis (OR 4.5, 95% CI 0.97 - 21.2, p = 0.055). Children with recurrent wheezing were significantly more often infected with a protozoan infection compared with children that did not suffer from recurrent wheezing in multivariable analysis (OR 6.7, 95% CI 1.5 – 30.5).

Discussion

This cross-sectional survey showed that Warao Amerindian children in Venezuela aged 0 to 2 years suffer from a high prevalence of atopic eczema and recurrent wheezing. Recurrent wheezing prevalence rates were significantly positively associated with protozoan infections while rates of atopic eczema were significantly higher in stunted children. Helminth infections were not significantly associated with either atopic eczema or recurrent wheezing.

The prevalence of recurrent wheezing in our study population was 23%. Similar prevalence rates of recurrent wheezing in children aged 0 to 2 years were observed in urban areas of Brazil and Norway [34, 35], although study definitions regarding the minimal number of wheezing episodes (respectively three in the first year of life and two in the first two years of life) were not identical to our study. In a rural area of Colombia, the prevalence of recurrent wheezing (≥3 episodes) in children aged 24 months was 14% [36]. Definitions of recurrent wheezing in young children used in different studies vary widely. Our definition of recurrent wheezing has been used previously in preschool children [37, 38]. In urban areas with hospitals keeping patient records, questionnaires for recurrent wheezing in infants can be validated by comparing the parental answers to questionnaires with diagnoses made by pediatric respiratory specialists and this has led to the use of such questionnaires in urban health centres in Latin America [39, 40]. The diagnostic value of these questionnaires in rural indigenous populations remains to be seen.

Almost one fifth of the children included in this survey were diagnosed with atopic eczema (19%). In Shanghai in children 3 to 6 years of age an overall atopic eczema prevalence of 8% was observed, ranging from 5% in rural areas to 13% in urban areas [5]. In Europe, the overall prevalence of atopic dermatitis in 1133 children living in five European countries in farming and non-farming rural areas was 16% (range 8%-30%) [41].

We observed a significantly higher prevalence of atopic eczema in children suffering from stunting compared with children who were not stunted and a trend towards more stunting in children with recurrent wheezing compared to children without recurrent wheezing. Stunting indicates chronic malnutrition. In children with malnutrition, cell-mediated (T-cell) immunity, IgA levels in secretions, complement levels, and phagocytosis are all diminished [42]. Whether stunted children with an altered immune response have a higher risk of atopic reactions than non-stunted children warrants further investigation. In the group of children with wasting, indicating acute malnutrition, we did not record cases of atopic eczema and only two cases of recurrent wheezing. As this acute presentation of malnutrition develops in a short period of time, it is possible that malnutrition-related alterations in the immune response that might be associated with the development of atopic eczema have not yet developed in children with an acute form of malnutrition.

The overall gastrointestinal parasitic infection prevalence in children 0 to 2 years of age in our study was 70%. The prevalence of helminth infections was 26%. Similar helminth infection prevalence rates in children under 2 years of age were observed in rural areas in other South American countries [24, 43, 44]. The prevalence of gastrointestinal protozoan infections in our study population was 59% with G. lamblia as the most prevalent protozoan infection, infecting 47% of the children. The prevalence of G. lamblia infections we observed is higher than prevalence rates in an earlier study performed in the Orinoco Delta between 2010 and 2011. This study included 141 children aged 1 to 15 years and recorded a protozoan infection prevalence of 65% and a G. lamblia infection prevalence of 37% [22]. In pre-school children, a higher prevalence of G. lamblia infections in the rainy season compared with the dry season has been observed [45]. Our study was performed in the rainy season while the earlier study was performed during a whole year, which can explain the higher prevalence of G. lamblia in our study compared to the earlier study. In other South American countries the prevalence of G. lamblia in children aged 0 to 2 years is approximately 20% [43, 44]. However, these studies detected G. lamblia infections only microscopically. We detected G. lamblia by both microscopy and real time PCR, a technique with a very high sensitivity for protozoan infections [28].

The presence of protozoan infections was significantly associated with a high prevalence of recurrent wheezing in our study. Two earlier studies performed in Venezuela in 1993 and 1998 showed similar positive associations between G. lamblia and allergic diseases [19, 20]. A recent Brazilian study showed no association between G. lamblia and symptoms of asthma or skin allergy [21]. However, all of these studies included children older than 2 years of age. Helminth infections were not associated with either recurrent wheezing or atopic eczema in our study while an inverse association between infection with different helminth species and allergic conditions has been reported in other studies [1618] However, the children included in these studies were also older than 2 years. The immune system of infants and young children shows great plasticity and is more amenable to modulation than the immune system of older children and adults [46]. Age is therefore likely to be a major determinant of the interaction between intestinal parasitic infections and the host immune respons and more studies including children younger than 2 years of age are warranted.

The interpretation of a diagnosis of recurrent wheezing in children younger than 2 years of age is questionable. Wheezy lower respiratory tract illnesses are common in early childhood and are often associated with viral infections, particularly with respiratory syncytial virus (RSV) [47, 48]. Recurrent wheezing in our study children could thus be the mere result of repeated viral infections rather than a marker for bronchial allergy. However, even if recurrent wheezing was caused by viral respiratory tract infections, wheezing episodes could still be related to an allergic predisposition of the child. Prospective studies show that infants with repeated episodes of viral bronchiolitis often develop allergic asthma during childhood [4951] and it has been suggested that a predisposition for bronchial obstructive disease underlies both recurrent wheezing in young children and asthma development during childhood [52]. In a recently published large prospective birth cohort study, two-third of the children with recurrent wheezing episodes by 2 years of age was diagnosed with asthma or bronchial hyper responsiveness or used asthma medication at 16 years of age [35]. Atopy as measured by skin prick tests and atopic dermatitis in infancy has also been identified as a predictor for the subsequent development of asthma [51, 53]. Another study among schoolchildren living in a poor rural region of tropical Latin America, showed a predominance of non-atopic compared with atopic wheeze. However the subjects of this study were between 6 and 16 years old and thus not comparable to our study population [54]. The positive association between atopic eczema and recurrent wheezing that we observed indicates that recurrent wheezing in our studied children could be a marker for susceptibility for atopic asthma. However, follow-up studies in this population at an older age are required to establish a possible association of recurrent wheezing with subsequent asthma development. Furthermore, it is recommendable to include other measures of atopy such as skin prick tests in future follow-up studies.

In this survey a stool sample was collected in 100 of the 229 subjects (44%). The prevalence of stunting was higher in children from whom stool samples were obtained than in children without a stool sample. A possible explanation for this finding is that parents of malnourished children were more likely to collect stool samples because of concerns about the state of health of their children.

The diagnosis of atopic eczema was based on the Nottingham- and SCORAD-protocol [30, 31]. Both instruments are designed for diagnosing clinical atopic dermatitis. Additional information about the skin condition and familiar predisposition was obtained in order to distinguish between atopic dermatitis and other skin conditions such as scabies and viral or antibiotic rash. However, we cannot exclude the possibility that the presence of other skin conditions has led to false-positive observations and overreporting of the prevalence rate of atopic eczema. We observed that atopic eczema in children was often not identified as a problem by their parents. Dermatitis and rash were attributed to sweating and often no treatment was given, even if a topical treatment was provided by a local nurse. Severe cases of dermatitis were recognized as aberrant and a reason to consult a doctor. Scratching, which can easily lead to secondary infections in this setting, was generally not considered to be a problem. As atopic eczema in young children can lead to significant health problems [55], qualitative studies are needed to determine whether parents have disease awareness of atopic eczema. Possibly, there is a need for health and educational services on this topic.

In addition to the already mentioned limitations, eg the interpretation of the diagnosis of recurrent wheezing and the lack of blood samples or skin-prick tests, there are several other limitations to our study, some of which are related to the challenging logistics of conducting an epidemiological study in an area with a poor infrastructure characterized by low literacy and poor access to health care. Although we performed a multivariable analysis taking into account possible confounders such as age and sex, unmeasured factors may have caused residual confounding. Male gender, low birth weight (<2,500 g), low gestational age (<37 weeks), breastfeeding for less than 6 months, congenital heart disease, family history of atopy, asthma, smoking exposure and stove warming, have been identified as significant risk factors for recurrent wheezing while the presence of pets at home seems to be a protective factor [56]. It is difficult to obtain information on birth weight and gestational age in the Warao population, because documentation on new-borns is not collected consistently. Most women deliver their children at home and do not visit a hospital. There are no records available on gestational age because women generally do not know their exact pregnancy duration. As virtually all Warao children are breastfed until at least 12 months of age, it is not likely that the lack of information on duration of breastfeeding has influenced our study results. The prevalence of congenital heart disease is unknown. Also, the lack of information on smoking exposure and the presence of pets in the household may have caused residual confounding.

Additionally, although included villages were chosen to be geographically spread throughout the Antionio Díaz municipality, no randomization procedure was performed for the selection of villages. If reported wheezing episodes were related to viral infections, substantial variation between communities in the prevalence of recurrent wheezing could be associated with the rapid spread of viral infections within communities. Because most Warao people live with several families together in one house, viral infections spread rapidly, leading to a rise in overall prevalence when a few community members become infected. Finally, the use of a questionnaire may have caused recall bias. However, a questionnaire is the only available instrument in the Warao population because hospital data on atopic diseases are scarce due to the lack of personal medical records.

Conclusions

Although it is generally assumed that in rural areas of developing countries allergic diseases are relatively uncommon compared to industrialized areas of developed and developing countries, a high prevalence of atopic eczema and recurrent wheezing in Warao children 0 to 2 years of age was observed. Chronic malnutrition was significantly associated with a high prevalence of atopic eczema in multivariable analysis. Protozoan infections were significantly associated with the presence of recurrent wheezing in multivariable analysis. No significant associations between helminth infections and atopic eczema or recurrent wheezing were observed. The immune regulatory mechanisms involved in the association between intestinal protozoan infections and allergic manifestations require further investigation. An integrated approach including improvement of the sanitary conditions, boosting agricultural productivity and creating awareness is needed to improve the health status and eliminate intestinal parasitic infections and immunopathologies in young Warao Amerindian children.

Notes

Declarations

Acknowledgements

The authors thank the participating families and the involved field workers, in particular Mailis Maes, Meyke Hermsen, Stèphan Kraai, Thor Kuchler and Jochem Burghouts. The PCR was facilitated by Titia Kortbeek and the Centre for Infectious Disease Control, RIVM, The Netherlands. Furthermore, we thank Sietze Brandes and Nahid Nozari for their expert technical assistance. Finally we thank Joanna in ‘t Hout for her professional statistical assistance. This study was supported by the Fundación para la Investigación en Micobacterias (FUNDAIM), Caracas, Venezuela. This work was also supported by ‘Integrated Microsystems for Biosensing (3E-01), FES0901:FES HTSM’, a project of NanoNextNL, a micro and nanotechnology consortium of the Government of the Netherlands and 130 partners.

Authors’ Affiliations

(1)
Laboratory of Pediatric Infectious Diseases, Department of Pediatrics, Radboud University Nijmegen Medical Centre
(2)
Laboratorio de Tuberculosis, Instituto de Biomedicina, Universidad Central de Venezuela, al lado del Hospital Vargas
(3)
Departamento de Pediatría, Hospital de Niños “J.M. de los Rios”
(4)
Escuela José María Vargas, Facultad de Medicina, Universidad Central de Venezuela, Ciudad Universitaria
(5)
Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM)

References

  1. Sly RM: Changing prevalence of allergic rhinitis and asthma. Ann Allergy Asthma Immunol. 1999, 82 (3): 233-248. 10.1016/S1081-1206(10)62603-8. 251–252View ArticlePubMedGoogle Scholar
  2. Aranzamendi C, Sofronic-Milosavljevic L, Pinelli E: Helminths: immunoregulation and inflammatory diseases—which side are trichinella spp. and toxocara spp. on?. J Parasitol Res. 2013, Article ID 329438, 11 pages, http://dx.doi.org/10.1155/2013/329438 Google Scholar
  3. Sears MR: Epidemiology of childhood asthma. Lancet. 1997, 350: 1015-1020. 10.1016/S0140-6736(97)01468-2.View ArticlePubMedGoogle Scholar
  4. Williams H, Robertson C, Stewart A, Aït-Khaled N, Anabwani G, Anderson R, Asher I, Beasley R, Björkstén B, Burr M, Clayton T, Crane J, Ellwood P, Keil U, Lai C, Mallol J, Martinez F, Mitchell E, Montefort S, Pearce N, Shah J, Sibbald B, Strachan D, von Mutius E, Weiland SK: Worldwide variations in the prevalence of symptoms of atopic eczema in the international study of asthma and allergies in childhood. J Allergy Clin Immunol. 1999, 103: 125-138. 10.1016/S0091-6749(99)70536-1.View ArticlePubMedGoogle Scholar
  5. Xu F, Yan S, Li F, Cai M, Chai W, Wu M, Fu C, Zhao Z, Kan H, Kang K, Xu J: Prevalence of childhood atopic dermatitis: an urban and rural community-based study in Shanghai, China. PLoS One. 2012, 7 (5): e36174-10.1371/journal.pone.0036174. doi:10.1371/journal.pone.0036174View ArticlePubMedPubMed CentralGoogle Scholar
  6. Perzanowski MS, Ng’ang’a LW, Carter MC, Odhiambo J, Ngari P, Vaughan JW, Chapman MD, Kennedy MW, Platts-Mills TAE: Atopy, asthma, and antibodies to Ascaris among rural and urban children in Kenya. J Pediatr. 2002, 140 (5): 582-588. 10.1067/mpd.2002.122937.View ArticlePubMedGoogle Scholar
  7. Lee SY, Kwon JW, Seo JH, Kim BJ, Yu J, Park KS, Kim H, Kim EJ, Lee JS, Hong SJ: Prevalence of atopy and allergic diseases in Korean children: associations with a farming environment and rural lifestyle. Int Arch Allergy Immunol. 2012, 158: 168-174. 10.1159/000330820.View ArticlePubMedGoogle Scholar
  8. Shpakou A, Brozek G, Stryzhak A, Neviartovich T, Zejda J: Allergic diseases and respiratory symptoms in urban and rural children in Grodno Region (Belarus). Pediatr Allergy Immunol. 2012, 23 (4): 339-346. 10.1111/j.1399-3038.2011.01263.x.View ArticlePubMedGoogle Scholar
  9. Amberbir A, Medhin G, Alem A, Britton J, Davey G, Venn A: The role of acetaminophen and geohelminth infection on the incidence of wheeze and eczema: a longitudinal birth-cohort study. Am J Respir Crit Care Med. 2011, 183 (2): 165-170. 10.1164/rccm.201006-0989OC.View ArticlePubMedGoogle Scholar
  10. Taborda-Barata L, Potter PC: Socio-epidemiological aspects of respiratory allergic diseases in Southern Africa. WAO J. 2012, 5: 1-8.Google Scholar
  11. Strachan DP: Hay fever, hygiene, and household size. BMJ. 1989, 299 (6710): 1259-1260. 10.1136/bmj.299.6710.1259.View ArticlePubMedPubMed CentralGoogle Scholar
  12. Maizels RM, Hewitson JP, Smith KA: Susceptibility and immunity to helminth parasites. Curr Opin Immunol. 2012, 24 (4): 459-466. 10.1016/j.coi.2012.06.003.View ArticlePubMedPubMed CentralGoogle Scholar
  13. Wilson MS, Taylor MD, Balic A, Finney CAM, Lamb JR, Maizels RM: Suppression of allergic airway inflammation by helminth-induced regulatory T cells. J Exp Med. 2005, 202 (9): 1199-1212. 10.1084/jem.20042572.View ArticlePubMedPubMed CentralGoogle Scholar
  14. Belkaid Y, Chen W: Regulatory ripples. Nat Immunol. 2010, 11 (12): 1077-1078. 10.1038/ni1210-1077.View ArticlePubMedPubMed CentralGoogle Scholar
  15. Alcantara-Neves NM, Badaro SJ, dos Santos MCA, Pontes-de-Carvalho L, Barreto ML: The presence of serum anti-Ascaris lumbricoides IgE antibodies and of Trichuris trichiura infection are risk factors for wheezing and/or atopy in preschool-aged Brazilian children. Respir Res. 2010, 11: 114-10.1186/1465-9921-11-114.View ArticlePubMedPubMed CentralGoogle Scholar
  16. Silva MTN, Souza VM, Bragagnoli G, Pereira TGR, Malagueño E: Atopic dermatitis and ascariasis in children aged 2 to 10 years. J Pediatr (Rio J). 2010, 86 (1): 53-58. 10.2223/JPED.1962.View ArticleGoogle Scholar
  17. Alcantara-Neves NM, Veiga RV, Dattoli VCC, Fiaccone RL, Esquivel R, Cruz AA, Cooper PJ, Rodrigues LC, Barreto ML: The effect of single and multiple infections on atopy and wheezing in children. J Allergy Clin Immunol. 2012, 129 (2): 359-367. 10.1016/j.jaci.2011.09.015. 367 e351-353View ArticlePubMedGoogle Scholar
  18. Feary J, Britton J, Leonardi-Bee J: Atopy and current intestinal parasite infection: a systematic review and meta-analysis. Allergy. 2011, 66 (4): 569-578. 10.1111/j.1398-9995.2010.02512.x.View ArticlePubMedGoogle Scholar
  19. Di Prisco MC, Hagel I, Lynch NR, Jiménez JC, Rojas R, Gil M, Mata E: Association between giardiasis and allergy. Ann Allergy Asthma Immunol. 1998, 81: 261-265. 10.1016/S1081-1206(10)62823-2.View ArticlePubMedGoogle Scholar
  20. Di Prisco MC, Hagel I, Lynch NR, Barrios RM, Alvarez N, López R: Possible relationship between allergic disease and infection by Giardia lamblia. Ann Allergy. 1993, 70 (3): 210-213.PubMedGoogle Scholar
  21. Souza VMO, Sales IRF, Peixoto DM, Costa VMA, Rizzo JA, Silva AR, Camilo RF, Pierotti FF, Solé D, Sarinho ESC: Giardia lamblia and respiratory allergies: a study of children from an urban area with a high incidence of protozoan infections. J Pediatr (Rio J). 2012, 88 (3): 233-238.Google Scholar
  22. Verhagen LM, Hermans PW, Warris A, de Groot R, Maes M, Villalba JA, del Nogal B, van den Hof S, Mughini Gras L, van Soolingen D, Pinelli E, de Waard JH: Helminths and skewed cytokine profiles increase tuberculin skin test positivity in Warao Amerindians. Tuberculosis (Edinb). 2012, 92 (6): 505-512. 10.1016/j.tube.2012.07.004.View ArticleGoogle Scholar
  23. Victora CG, de Onis M, Hallal PC, Blössner M, Shrimpton R: Worldwide timing of growth faltering: revisiting implications for interventions. Pediatrics. 2010, 125 (3): e473-e480. 10.1542/peds.2009-1519.View ArticlePubMedGoogle Scholar
  24. Gyorkos TW, Maheu-Giroux M, Casapia M, Joseph SA, Creed-Kanashiro H: Stunting and helminth infection in early preschool-age children in a resource-poor community in the Amazon lowlands of Peru. Trans R Soc Trop Med Hyg. 2011, 105 (4): 204-208. 10.1016/j.trstmh.2010.12.003.View ArticlePubMedGoogle Scholar
  25. Verhagen LM, Incani RN, Franco CR, Ugarte A, Cadenas Y, Sierra Ruiz CI, Hermans PW, Hoek D, Campos Ponce M, de Waard JH, Pinelli E: High malnutrition rate in Venezuelan Yanomami compared to Warao Amerindians and Creoles: significant associations with intestinal parasites and anemia. PLoS One. 2013, 8 (10): e77581-10.1371/journal.pone.0077581.View ArticlePubMedPubMed CentralGoogle Scholar
  26. Ash LR, Orihel TC, Savioli L, Sin AS, Montresor A, Renganathan E: WHO: Bench Aids for the Diagnosis of Intestinal Parasitoses 1994. Programme of Intestinal Parasitic Infections. Division of Communicable Diseases. 1994, Geneva, Switzerland: World Health OrganizationGoogle Scholar
  27. Verweij JJ, Mulder B, Poell B, van Middelkoop D, Brienen EA, van Lieshout L: Real-time PCR for the detection of Dientamoeba fragilis in fecal samples. Mol Cell Probes. 2007, 21 (5–6): 400-404.View ArticlePubMedGoogle Scholar
  28. Verweij JJ, Blangé RA, Templeton K, Schinkel J, Brienen EA, van Rooyen MA, van Lieshout L, Polderman AM: Simultaneous detection of Entamoeba histolytica, Giardia lamblia, and Cryptosporidium parvum in fecal samples by using multiplex real-time PCR. J Clin Microbiol. 2004, 42 (1220e3): 1120-1223.Google Scholar
  29. Basuni M, Muhi J, Othman N, Verweij JJ, Ahmad M, Miswan N, Rahumatullah A, Aziz FA, Zainudin NS, Noordin R: A pentaplex real-time polymerase chain reaction asssay for detection of four species of soil-transmitted helminths. Am J Trop Med Hyg. 2011, 84 (2): 338-343. 10.4269/ajtmh.2011.10-0499.View ArticlePubMedPubMed CentralGoogle Scholar
  30. Williams HC, Flohr C: United Kingdom Working Party (UKWP) criteria/ Nottingham protocol 2011. [http://www.nottingham.ac.uk/dermatology/eczema/index.html.]
  31. Stalder JF: SCORAD protocol 2011. [http://adserver.sante.univ-nantes.fr/Scorad.html.]
  32. de Onis M, Onyango A, Borghi E, Siyam A, Pinol A, members of World Health Organization Multicentre Growth Reference Study Group: WHO Child Growth Standards: Length/Height-for-Age, w.-f.-a., Weight-for-Length, Weight-for-Height and Body Mass Index-for-Age: Methods and Development. 2006, Geneva, Switzerland: World Health OrganizationGoogle Scholar
  33. Blössner M, Siyam A, Borghi E, de Onis M, Onyango A, Yang H: Software: WHO Anthro version 3.2.2, 2011. [http://www.who.int/childgrowth/software/en/]
  34. Dela Bianca AC, Wandalsan GF, Mallol J, Solé D: Prevalence and severity of wheezing in the first year of life. J Bras Pneumol. 2010, 36 (4): 402-409. 10.1590/S1806-37132010000400003.View ArticlePubMedGoogle Scholar
  35. Hovland V, Riiser A, Mowinckel P, Carlsen KH, Lødrup Carlsen KC: The significance of early recurrent wheeze for asthma outcomes in late childhood. Eur Respir J. 2013, 41 (4): 838-845. 10.1183/09031936.00071512.View ArticlePubMedGoogle Scholar
  36. Acevedo N, Sánchez J, Zakzuk J, Bornacelly A, Quiróz C, Alvarez Á, Puello M, Mendoza K, Martínez D, Mercado D, Jiménez S, Caraballo L: Particular characteristics of allergic symptoms in tropical environments: follow up to 24 months in the FRAAT birth cohort study. BMC Pulm Med. 2012, 12: 13-10.1186/1471-2466-12-13.View ArticlePubMedPubMed CentralGoogle Scholar
  37. Hermann C, Westergaard T, Pedersen BV, Wohlfahrt J, Høst A, Melbye M: A comparison of risk factors for wheeze and recurrent cough in preschool children. Am J Epidemiol. 2005, 15: 345-350.View ArticleGoogle Scholar
  38. Beigelman A, King TS, Mauger D, Zeiger RS, Strunk RC, Kelly HW: Do oral corticosteroids reduce the severity of acute lower respiratory tract illnesses in preschool children with recurrent wheezing?. J Allergy Clin Immunol. 2013, 131: 1518-1525. 10.1016/j.jaci.2013.01.034.View ArticlePubMedGoogle Scholar
  39. Mallol J, García-Marcos L, Aguirre V, Martinez-Torres A, Perez-Fernández V, Gallardo A: The international study of wheezing in infants: questionnaire validation. Int Arch Allergy Immunol. 2007, 144: 44-50. 10.1159/000102613.View ArticlePubMedGoogle Scholar
  40. Mallol J, García-Marcos L, Dirceu Solé, the EISL Study Group: International prevalence of recurrent wheezing during the first year of life: variability, treatment patterns and use of health resources. Thorax. 2010, 65: 1004-1009. 10.1136/thx.2009.115188.View ArticlePubMedGoogle Scholar
  41. Karvonen AM, Hyvärinen A, Gehring U, Korppi M, Doekes G, Riedler J, Braun-Fahrländer C, Bitter S, Schmid S, Keski-Nisula L, Roponen M, Kaulek V, Dalphin JC, Pfefferle PI, Renz H, Büchele G, von Mutius E, Pekkanen J, PASTURE Study Group: Exposure to microbial agents in house dust and wheezing, atopic dermatitis and atopic sensitization in early childhood: a birth cohort study in rural areas. Clin Exp Allergy. 2012, 42 (8): 1246-1256. 10.1111/j.1365-2222.2012.04002.x.View ArticlePubMedGoogle Scholar
  42. Nichols BL: Malnutrition in developing countries: Clinical assessment. [http://www.uptodate.com/contents/malnutrition-in-developing-countries-clinical-assessment?source=search_result&search=malnutrition+immune+system&selectedTitle=1~150]
  43. Alvarado BE, Vásquez LR: Determinantes sociales, prácticas de alimentación y consecuencias nutricionales del parasitismo intestinal en niños de 7 a 18 meses de edad en Guapi, Cauca. Biomedica. 2006, 26: 82-94.View ArticlePubMedGoogle Scholar
  44. Maia MMM, Fausto M, Vieira ELM, Benetton MLFN, Carneiro M: Intestinal parasitic infection and associated risk factors, among children presenting at outpatient clinics in Manaus, Amazonas state, Brazil. Ann Trop Med Parasitol. 2009, 103 (7): 583-591. 10.1179/000349809X12459740922417.View ArticlePubMedGoogle Scholar
  45. Siwila J, Phiri IG, Enemark HL, Nchito M, Olsen A: Seasonal prevalence and incidence of Cryptosporidium spp. and Giardia duodenalis and associated diarrhoea in children attending pre-school in Kafue, Zambia. Trans R Soc Trop Med Hyg. 2011, 105 (2): 102-108. 10.1016/j.trstmh.2010.10.004.View ArticlePubMedGoogle Scholar
  46. Djuardi Y, Wammes LJ, Supali T, Sartano E, Yazda Nbakhsh Y: Immunological footprint: the development of a child’s immune system in environments rich in microorganisms and parasites. Parasitology. 2011, 138 (12): 1508-1518. 10.1017/S0031182011000588.View ArticlePubMedGoogle Scholar
  47. Wright AL, Taussig LM, Ray CG, Harrison HR, Holberg CJ: The Tucson Children’s Respiratory Study. II. Lower respiratory tract illness in the first year of life. Am J Epidemiol. 1989, 129 (6): 1232-1246.PubMedGoogle Scholar
  48. Alba Moreno FA, Alsina Donadeu J: Estudio clínico-epidemiológico de las enfermedades del tracto respiratorio inferior con sibilancias en menores de 2 años y factores de riesgo asociados. An Esp Pediatr. 1999, 50 (4): 379-383.PubMedGoogle Scholar
  49. Sigurs N, Bjarnason R, Sigurbergsson F, Kjellman B: Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7. Am J Respir Crit Care Med. 2000, 161 (5): 1501-1507. 10.1164/ajrccm.161.5.9906076.View ArticlePubMedGoogle Scholar
  50. Sigurs N, Bjarnason R, Sigurbergsson F, Kjellman B, Björkstén B: Asthma and immunoglobulin E antibodies after respiratory syncytial virus bronchiolitis: a prospective cohort study with matched controls. Pediatrics. 1995, 95 (4): 500-505.PubMedGoogle Scholar
  51. Kusel MM, Kebadze T, Johnston SL, Holt PG, Sly PD: Febrile respiratory illnesses in infancy and atopy are risk factors for persistent asthma and wheeze. Eur Respir J. 2012, 39 (4): 876-882. 10.1183/09031936.00193310.View ArticlePubMedGoogle Scholar
  52. Beigelman A, Bacharier LB: The role of early life viral bronchiolitis in the inception of asthma. Curr Opin Allergy Clin Immunol. 2013, 13 (2): 211-216. 10.1097/ACI.0b013e32835eb6ef.View ArticlePubMedPubMed CentralGoogle Scholar
  53. Reijonen TM, Kotaniemi-Syrjänen A, Korhonen K, Korppi M: Predictors of asthma three years after hospital admission for wheezing in infancy. Pediatrics. 2000, 106 (6): 1406-1412. 10.1542/peds.106.6.1406.View ArticlePubMedGoogle Scholar
  54. Moncayo AL, Vaca M, Oviedo G, Erazo S, Quinzo I, Fiaccone RL, Chico ME, Barreto ML, Cooper PJ: Risk factors for atopic and non-atopic asthma in a rural area of Ecuador. Thorax. 2010, 65: 409e416-doi:10.1136/thx.2009.126490View ArticleGoogle Scholar
  55. Paller AS, Chren MM: Out of the skin of babes: measuring the full impact of atopic dermatitis in infants and young children. J Invest Dermatol. 2012, 132 (11): 2494-2496. 10.1038/jid.2012.354.View ArticlePubMedGoogle Scholar
  56. Bozaykut A, Paketci A, Sezer RG, Paketci C: Evaluation of risk factors for recurrent wheezing episodes. J Clin Med Res. 2013, 5 (5): 395-400. doi:10.4021/jocmr1543w.)PubMedPubMed CentralGoogle Scholar
  57. Pre-publication history

    1. The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2334/14/293/prepub

Copyright

© Overeem et al.; licensee BioMed Central Ltd. 2014

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Advertisement